| J3262 | Injection, tocilizumab, 1 mg | 40,780 | $10 | $203.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,060 | $30 | $183.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,650 | $30 | $158.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 30,400 | $1 | $121.6K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,140 | $30 | $106.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 180 | $140 | $24.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $110 | $23.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $90 | $22.1K |
| J0897 | Injection, denosumab, 1 mg | 1,080 | $20 | $19.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $50 | $8.4K |